ATYR Q3 2021 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena

ATYRaTyr Pharma, Inc.

$89M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$8M

Net Income

-$8M

EPS (Diluted)

$-0.42

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$12M

Stock-Based Comp.

$442,000

Balance Sheet

Total Assets

$124M

Total Liabilities

$6M

Stockholders' Equity

$118M

Cash & Equivalents

$60M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$148,000	-100.0%
Gross Profit	$0	$148,000	-100.0%
Operating Income	-$8M	-$7M	-18.7%
Net Income	-$8M	-$7M	-16.2%